Sun Pharmaceutical: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
Rescuing 2 sources and tagging 0 as dead.) #IABot (v2.0.8 |
Rescuing 2 sources and tagging 0 as dead.) #IABot (v2.0.8.1 |
||
Baris 31:
Pada 6 April 2014, Sun Pharma mengumumkan bahwa mereka akan mengakuisisi 100% [[Ranbaxy Laboratories]] Ltd,<ref>{{cite web|url=http://www.btvin.com/videos/watch/7263/sun-ranbaxy-deal:-ap-hc-green-signal-|title=BTvIn – Sun-Ranbaxy Deal: AP HC Green Signal|author=Prabha Hedge|work=Btvin|accessdate=2 July 2015|archive-date=2016-03-31|archive-url=https://web.archive.org/web/20160331160216/http://www.btvin.com/videos/watch/7263/sun-ranbaxy-deal:-ap-hc-green-signal-|dead-url=yes}}</ref> dalam transaksi semua saham, senilai $4 miliar. [[Daiichi Sankyo]] dari Jepang memiliki 63,4% saham di Ranbaxy. Setelah akuisisi ini, Sun Pharma telah menjadi perusahaan farmasi terbesar di India, perusahaan Farmasi India terbesar di AS, dan perusahaan generik terbesar ke-5 di dunia.<ref>{{cite web|url=http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-to-buy-ranbaxy-in-3-2-bn-deal/articleshow/33365818.cms|title=Sun Pharma to buy Ranbaxy in $3.2 bn deal|work=timesofindia-economictimes|accessdate=2 July 2015}}</ref>
Pada bulan Desember 2014, Komisi Persaingan Usaha India menyetujui tawaran Sun Pharma senilai $3,2 miliar untuk membeli Ranbaxy, tetapi memerintahkan perusahaan tersebut untuk mendivestasikan tujuh produk untuk memastikan kesepakatan tersebut tidak merugikan persaingan.<ref>{{cite web|url=http://in.reuters.com/article/2014/12/09/ranbaxy-lab-sun-pharma-regulator-idINKBN0JM1AY20141209|title=CCI clears Sun Pharma-Ranbaxy deal|work=Reuters India|accessdate=2 July 2015|archive-date=2015-07-30|archive-url=https://web.archive.org/web/20150730120501/http://in.reuters.com/article/2014/12/09/ranbaxy-lab-sun-pharma-regulator-idINKBN0JM1AY20141209|dead-url=yes}}</ref><ref name="auto">{{cite web|url=http://in.reuters.com/article/2015/03/03/gsk-sun-pharma-deals-idINL4N0W520E20150303|title=UPDATE 1-India's Sun Pharma to buy Glaxo's opiates business in Australia|work=Reuters India|accessdate=2 July 2015|archive-date=2015-09-13|archive-url=https://web.archive.org/web/20150913160030/http://in.reuters.com/article/2015/03/03/gsk-sun-pharma-deals-idINL4N0W520E20150303|dead-url=yes}}</ref>
== Referensi ==
| |||